Government-owned and financially ailing AI has been dropping its economy class fares to the level of low-cost carriers.
Telcos likely to get to switch from 2,300-MHz band for 4G services.
Regulator mentions Wockhardt as manufacturer but firm says it only markets drug.
The patent office said Pfizer's claimed patent for Sutent, a cancer drug, did not involve any inventive step.
Health & family welfare ministry's proposal seeks to restrict sale of antibiotics to check self-medication.
Also being considered is Rs 50 lakh-1 cr taxable income bracket.
Decades of military rule kept the country closed to foreign investors.
Prodded by patent cliff & increasing competition, it files application for foray into injectible oncology segment.
Says company yet to file audited accounts, without which it can't proceed.
Firms could lose licence if products not launched within 6 months of approval.
The department of telecommunications, in the draft universal licence guidelines to be signed with telcos which recently won spectrum in the 1800 MHz auction of November, has included a new clause for foreign companies.
Three Indian companies registered with the Registrar of Companies use the same brand name.
Agenda for FIPB meeting on Jan 18 doesn't mention its application.
DEA official writes to DIPP suggesting that govt needs to understand what has been left out, and why, in the revised application of the retailer.
Divestment in top PSUs could make the ETF as big as Rs 30,000 crore.
Executives caused loss of Rs 11 cr, according to police SIT.
Masood Imad, media secretary to the Maldivian President, says: "We have asked MACL to hire a firm like KPMG to conduct a forensic audit of the firm's accounts.
Did GMR Infra get a sweet deal from former Maldivian president that turned sour as a new government came to power?
An interview with Ranbaxy CEO and MD Arun Sawhney on the changes in the past four years and how the company plans to address the US concerns.
SFIO official refuses to reveal the nature of additional charges found during investigation.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances